ORIXHA

DeepTech start-up with JEU status, ORIXHA leverages 10 years of academic research in hypothermia and liquid ventilation to develop innovative Medical Devices for Emergency and Intensive Care Healthcare Professionals.

Our experimental device LV4C (Liquid Ventilation for Cooling) performs utra-rapid induction of therapeutic hypothermia for cardiac arrest patients. LV4C is expected to be validated on patients in 2022.